SOPHARMA AD (82/2023) Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of 29 June 2023.
Report no 82/2023
- 30.06.2023, 13:18
- Kategoria: Biznes i finanse
- Źródło: ESPI
Sopharma AD-BG11SOSOBT18-SOPHARMA
-
-
SOPHARMA AD (81/2023) Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 28 June 2023.
Report no 81/2023- 29.06.2023, 14:04
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (80/2023) Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of 28 June 2023.
Report no 80/2023- 29.06.2023, 10:06
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (79/2023) Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 27 June 2023.
Report no 79/2023- 28.06.2023, 12:06
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (78/2023) Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of 27 June 2023.
Report no 78/2023- 28.06.2023, 09:51
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (77/2023) Notification from Bissera Lazarova under Art. 19 of Regulation (EU) No 596/2014 of 26 June 2023.
Report no 77/2023- 27.06.2023, 15:36
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (76/2023) Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of 26 June 2023.
Report no 76/2023- 27.06.2023, 15:30
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (75/2023) Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of 26 June 2023.
Report no 75/2023- 27.06.2023, 15:25
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (74/2023) Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of 23 June 2023.
Report no 74/2023- 26.06.2023, 10:30
- Kategoria: Biznes i finanse
- Źródło: ESPI
